Some patients treated with immunotherapy may develop lifelong endocrine conditions requiring ongoing hormone replacement, insulin therapy and long-term monitoring, according to Vi ...

Anton M. Kolomeyer, MD, PhD, a retina specialist at NJRetina, spoke with The American Journal of Managed Care ® about ...

Published results showed patients who received a higher number of corticosteroid injections before total shoulder ...

Please provide your email address to receive an email when new articles are posted on . Eylea HD allowed for longer treatment intervals compared with Eylea and showed similar safety and efficacy.

A panelist discusses how the injectable combination of cabotegravir and rilpivirine performed well in the real-world OPERA cohort, with over 95% of patients maintaining virologic suppression. However, ...

The treatment, now being offered at Royal Cornwall Hospitals NHS Trust (RCHT), is an injectable form of pembrolizumab (Keytruda).